FEops

Company profile

About FEops

FEops is a medical technology company specializing in AI-powered predictive simulation solutions for structural heart interventions. The company's flagship product, FEops HEARTguide™, is a cloud-based procedure planning platform specifically developed for interventional cardiologists to plan percutaneous procedures quickly and accurately. The platform combines finite element simulation technology with AI-based anatomical analysis to deliver predictive insights that improve procedural outcomes. FEops HEARTguide™ enables physicians to select optimal device sizes and implant positions by predicting device apposition, frame deformation, and compression rates for specific patient anatomies. The platform provides semi-automatic identification and measurement of anatomical landmarks through its DICOM interface, along with 3D visualization and image reconstruction capabilities. Clinical workflows are available for Left Atrial Appendage Occlusion (LAAO), Transcatheter Aortic Valve Implantation (TAVI), and Transcatheter Mitral Valve Replacement (TMVR). The platform has demonstrated clinically proven results, including a 15% reduction in closure devices used and a twofold increase in procedural success rates in the PREDICT-LAA study. In the PRECISE-TAVI study, 35% of pre-procedural decisions were changed using the platform, resulting in favorable clinical outcomes. FEops HEARTguide™ serves interventional cardiologists, medical care providers, and researchers, offering secure collaborative features for case sharing with peers and industry partners. The company continues to innovate with new features for TAVI lifetime management and future valve-in-valve procedures.

Company description · FEops official website